SB 227 Modifies provisions relating to the collateral source rule and provides that parties may introduce evidence of the cost, rather than the value, of the medical treatment rendered
Sponsor: Emery
LR Number: 1240S.01I Fiscal Notes
Committee: Small Business, Insurance and Industry
Last Action: 5/15/2015 - S Informal Calendar S Bills for Perfection--SB 227-Emery, with SS (pending) Journal Page:
Title: Calendar Position:
Effective Date: August 28, 2015

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2015 Senate Bills

Current Bill Summary


SS/SB 227 - This act provides that a defendant's payment of a plaintiff's special damages prior to trial shall not be admissible or recoverable from that defendant. A defendant who makes such payment of special damages shall not be able to receive a credit or deduction of that amount from the final judgment, unless such payments have been included in the plaintiff's claim for special damages at trial.

This act provides that the parties may introduce evidence of the cost, rather than the value, of the medical treatment rendered, and repeals a provision of law which provides that there is a rebuttal presumption that the value of the medical treatment provided is represented by the dollar amount necessary to satisfy the financial obligation to the health care provider. The cost of any medical treatment shall not exceed the dollar amount paid for by any source to satisfy the financial obligation of the health care provider for the treatment.

Evidence presented regarding medical treatment rendered shall be presented in terms of the past or projected actual cost necessary to satisfy the cost of such treatment and without reference to any billed charges in excess of such costs.

This act is similar to HB 596 (2015) and SB 799 (2014).

JESSI BAKER